The FDA has issued premarket approval for ReLEx SMILE to treat myopia with astigmatism, Zeiss announced in a press release.
The procedure, which is performed with the VisuMax femtosecond laser, may be potentially less disruptive to corneal surface tissue due to a small entry incision.
“The expansion of myopia treatment to patients with astigmatism will enable current and future SMILE surgeons to expand their patient base, paving the way for a new generation of refractive surgery patients,” Jim Mazzo, global president ophthalmic devices at Zeiss, said in the release.
Uncategorized